AdvanSource Biomaterials Corporation (OTCMKTS:ASNB) Files An 8-K Entry into a Material Definitive Agreement
AdvanSource Biomaterials Corp Exhibit
EX-2.1 2 f8k1219ex2-1_advansource.htm ASSET PURCHASE AGREEMENT Exhibit 2.1 Execution Version Redactions with respect to certain portions hereof are denoted with “***” ASSET PURCHASE AGREEMENT BY AND BETWEEN MITSUBISHI CHEMICAL PERFORMANCE POLYMERS,…
To view the full exhibit click here
About AdvanSource Biomaterials Corporation (OTCMKTS:ASNB)
AdvanSource Biomaterials Corporation develops polymer materials. The Company’s biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The Company manufactures and sells its polymers under the trade names, including ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane and PolyBlend. The Company also offers HydroMed. It also manufactures specialty hydrophilic polyurethanes. It manufactures and sells its HydroThane polymers to medical device manufacturers that are evaluating HydroThane for use in their products. Its HydroThane is a thermoplastic, water-absorbing and polyurethane elastomer. It manufactures polymeric materials with a range of physical and biological properties. The Company manufactures polymeric materials with a range of physical and biological properties. The Company’s polymers are available with characteristics, such as biodurability, biocompatibility, lubricity and antimicrobial properties.
